These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 25703650

  • 1. Is magnetic resonance imaging of hepatic hemangioma any different in liver fibrosis and cirrhosis compared to normal liver?
    Duran R, Ronot M, Di Renzo S, Gregoli B, Van Beers BE, Vilgrain V.
    Eur J Radiol; 2015 May; 84(5):816-22. PubMed ID: 25703650
    [Abstract] [Full Text] [Related]

  • 2. Hepatic hemangiomas: factors associated with T2 shine-through effect on diffusion-weighted MR sequences.
    Duran R, Ronot M, Kerbaol A, Van Beers B, Vilgrain V.
    Eur J Radiol; 2014 Mar; 83(3):468-78. PubMed ID: 24364922
    [Abstract] [Full Text] [Related]

  • 3. MR features of small hepatocellular carcinoma in normal, fibrotic, and cirrhotic livers: a comparative study.
    Sheng RF, Zeng MS, Ji Y, Yang L, Chen CZ, Rao SX.
    Abdom Imaging; 2015 Oct; 40(8):3062-9. PubMed ID: 26329976
    [Abstract] [Full Text] [Related]

  • 4. Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions.
    Ichikawa T, Haradome H, Hachiya J, Nitatori T, Araki T.
    AJR Am J Roentgenol; 1998 Feb; 170(2):397-402. PubMed ID: 9456953
    [Abstract] [Full Text] [Related]

  • 5. MR comparative study of combined hepatocellular-cholangiocarcinoma in normal, fibrotic, and cirrhotic livers.
    Sheng RF, Xie YH, Ji Y, Chen CZ, Yang L, Jin KP, Zeng MS.
    Abdom Radiol (NY); 2016 Nov; 41(11):2102-2114. PubMed ID: 27315077
    [Abstract] [Full Text] [Related]

  • 6. Hemangioma in the cirrhotic liver: diagnosis and natural history.
    Brancatelli G, Federle MP, Blachar A, Grazioli L.
    Radiology; 2001 Apr; 219(1):69-74. PubMed ID: 11274536
    [Abstract] [Full Text] [Related]

  • 7. Hepatic cavernous hemangioma: appearance on T2-weighted fast spin-echo MR imaging with and without fat suppression.
    Soyer P, Dufresne AC, Somveille E, Scherrer A.
    AJR Am J Roentgenol; 1997 Feb; 168(2):461-5. PubMed ID: 9016227
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Receiver operating characteristic analysis of diffusion-weighted magnetic resonance imaging in differentiating hepatic hemangioma from other hypervascular liver lesions.
    Vossen JA, Buijs M, Liapi E, Eng J, Bluemke DA, Kamel IR.
    J Comput Assist Tomogr; 2008 Feb; 32(5):750-6. PubMed ID: 18830105
    [Abstract] [Full Text] [Related]

  • 10. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
    Tang Y, Yamashita Y, Arakawa A, Namimoto T, Mitsuzaki K, Abe Y, Katahira K, Takahashi M.
    AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
    [Abstract] [Full Text] [Related]

  • 11. Differentiation between cavernous hemangiomas and untreated malignant neoplasms of the liver with free-breathing diffusion-weighted MR imaging: comparison with T2-weighted fast spin-echo MR imaging.
    Soyer P, Corno L, Boudiaf M, Aout M, Sirol M, Placé V, Duchat F, Guerrache Y, Fargeaudou Y, Vicaut E, Pocard M, Hamzi L.
    Eur J Radiol; 2011 Nov; 80(2):316-24. PubMed ID: 20800983
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic value of diffusion weighted MRI and ADC in differential diagnosis of cavernous hemangioma of the liver.
    Tokgoz O, Unlu E, Unal I, Serifoglu I, Oz I, Aktas E, Caglar E.
    Afr Health Sci; 2016 Mar; 16(1):227-33. PubMed ID: 27358636
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Addition of gadolinium chelates to heavily T2-weighted MR imaging: limited role in differentiating hepatic hemangiomas from metastases.
    Bennett GL, Petersein A, Mayo-Smith WW, Hahn PF, Schima W, Saini S.
    AJR Am J Roentgenol; 2000 Feb; 174(2):477-85. PubMed ID: 10658728
    [Abstract] [Full Text] [Related]

  • 15. Comparison of diffusion-weighted with T2-weighted Imaging for detection of small hepatocellular carcinoma in cirrhosis: preliminary quantitative study at 3-T.
    Wang H, Wang XY, Jiang XX, Ye ZX.
    Acad Radiol; 2010 Feb; 17(2):239-43. PubMed ID: 19962912
    [Abstract] [Full Text] [Related]

  • 16. T2-weighted MR imaging in the assessment of cirrhotic liver.
    Hussain HK, Syed I, Nghiem HV, Johnson TD, Carlos RC, Weadock WJ, Francis IR.
    Radiology; 2004 Mar; 230(3):637-44. PubMed ID: 14739306
    [Abstract] [Full Text] [Related]

  • 17. Hepatic hemangioma: correlation of enhancement types with diffusion-weighted MR findings and apparent diffusion coefficients.
    Goshima S, Kanematsu M, Kondo H, Yokoyama R, Kajita K, Tsuge Y, Shiratori Y, Onozuka M, Moriyama N.
    Eur J Radiol; 2009 May; 70(2):325-30. PubMed ID: 18321673
    [Abstract] [Full Text] [Related]

  • 18. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver.
    Holland AE, Hecht EM, Hahn WY, Kim DC, Babb JS, Lee VS, West AB, Krinsky GA.
    Radiology; 2005 Dec; 237(3):938-44. PubMed ID: 16306035
    [Abstract] [Full Text] [Related]

  • 19. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging.
    Nasu K, Kuroki Y, Nawano S, Kuroki S, Tsukamoto T, Yamamoto S, Motoori K, Ueda T.
    Radiology; 2006 Apr; 239(1):122-30. PubMed ID: 16493012
    [Abstract] [Full Text] [Related]

  • 20. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
    Low RN, Francis IR, Herfkens RJ, Jeffrey RB, Glazer GM, Foo TK, Shimakawa A, Pelc NJ.
    AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.